NDC Package 55111-652-37 Bivalirudin

Injection Intracavernous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
55111-652-37
Package Description:
10 VIAL, SINGLE-DOSE in 1 CARTON / 1 INJECTION in 1 VIAL, SINGLE-DOSE (55111-652-07)
Product Code:
Proprietary Name:
Bivalirudin
Non-Proprietary Name:
Bivalirudin
Substance Name:
Bivalirudin
Usage Information:
Bivalirudin for injection is indicated for use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA).
11-Digit NDC Billing Format:
55111065237
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
10 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 308769 - bivalirudin 250 MG Injection
  • RxCUI: 308769 - bivalirudin 250 MG (as bivalirudin trifluoroacetate 275 MG) per 5 ML Injection
  • RxCUI: 308769 - bivalirudin 50 MG/ML Injection
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Dr. Reddy's Laboratories Limited
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Intracavernous - Administration within a pathologic cavity, such as occurs in the lung in tuberculosis.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA201577
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    05-31-2017
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 55111-652-37?

    The NDC Packaged Code 55111-652-37 is assigned to a package of 10 vial, single-dose in 1 carton / 1 injection in 1 vial, single-dose (55111-652-07) of Bivalirudin, a human prescription drug labeled by Dr. Reddy's Laboratories Limited. The product's dosage form is injection and is administered via intracavernous form.This product is billed for "EA" each discreet unit and contains an estimated amount of 10 billable units per package.

    Is NDC 55111-652 included in the NDC Directory?

    Yes, Bivalirudin with product code 55111-652 is active and included in the NDC Directory. The product was first marketed by Dr. Reddy's Laboratories Limited on May 31, 2017 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 55111-652-37?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 10.

    What is the 11-digit format for NDC 55111-652-37?

    The 11-digit format is 55111065237. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-255111-652-375-4-255111-0652-37